PlantArcBio's Game-Changing DIPPER™ Platform Receives Patents in U.S. and South Korea

PlantArcBio Secures Patents for DIPPER™ Technology

PlantArcBio, an Israeli ag-biotech company, has made a significant milestone with the recent patent grants for its innovative technology, the DIPPER™ platform, in both the United States and South Korea. This breakthrough technology is gaining attention due to its ability to optimize gene expression in agricultural crops through advanced gene-editing processes.

Transforming Plant Biotechnology

The DIPPER™ platform represents a cutting-edge approach in the realm of plant biotechnology, focusing on enhancing the efficiency and precision of gene-editing techniques like CRISPR. Unlike traditional methodologies that often rely on trial-and-error, the DIPPER™ platform utilizes a high-throughput, in planta system. This sophisticated system systematically identifies DNA regulatory and coding elements that are instrumental in maximizing gene expression and performance across various crops and traits.

One of the most pressing challenges in the development of gene-edited crops is the precise identification of DNA modifications that enhance plant functionality. Traditional methods typically focus on deleting genes, which can yield less targeted results. In contrast, the DIPPER™ technology offers a more data-driven, accurate way to pinpoint optimal DNA alterations, significantly reducing the time required to develop new traits. This advantage not only expedites the introduction of new crop traits into the market but also supports stakeholders in the agricultural industry, including farmers and consumers, who benefit from enhanced crop yields and improved product resilience.

A Commitment to Sustainable Agriculture

Dror Shalitin, CEO of PlantArcBio, emphasized the strategic importance of this development: "The swift granting of these patents underscores PlantArcBio's commitment to delivering cutting-edge, scalable solutions for global agriculture. Our DIPPER™ platform is a true game-changer that accelerates the development of vital traits such as drought tolerance, yield improvement, herbicide resistance, and nutritional enhancement. By leveraging this technology, farmers can more effectively meet the escalating demands for sustainable food production in the face of a growing global population."

The issuance of these patents not only strengthens PlantArcBio’s position in the market but also highlights the potential of the DIPPER™ platform as essential for the successful implementation of gene-editing tools like CRISPR in key crops such as corn, soybean, wheat, rice, and various vegetables. The platform opens up avenues for the development of novel traits and allows for quicker commercialization, thereby placing PlantArcBio at the forefront of innovation in modern agriculture.

About PlantArcBio

Founded with a mission to improve global food security, PlantArcBio is dedicated to developing gene discovery and RNAi-based solutions that enhance crop traits and biologically control pests. The company's proprietary technologies, including the DIP™ and DIPPER™ platforms, are designed to unlock new pathways in genetic improvement, yielding significant benefits for agricultural productivity and sustainability.

Strategic partnerships with industry leaders such as ICL, Gadot-Agro, KWS, Rallis, and TATA's subsidiary TMG enable PlantArcBio to combine their innovative technologies with practical applications in the agri-business sector. This collaborative effort increases the reach and impact of their advancements, ultimately benefiting the broader agricultural community and consumers.

For more information about PlantArcBio and its revolutionary DIPPER™ platform, please visit their official website or contact their media team.